These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1851 related articles for article (PubMed ID: 25261849)
1. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells. Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849 [TBL] [Abstract][Full Text] [Related]
2. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway. Cui W; Zhang S; Shan C; Zhou L; Zhou Z FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162 [TBL] [Abstract][Full Text] [Related]
3. Differential Expression of MicroRNA-19b Promotes Proliferation of Cancer Stem Cells by Regulating the TSC1/mTOR Signaling Pathway in Multiple Myeloma. Wang N; Liang X; Yu W; Zhou S; Fang M Cell Physiol Biochem; 2018; 50(5):1804-1814. PubMed ID: 30396185 [TBL] [Abstract][Full Text] [Related]
4. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-101 mediates the suppressive effect of laminar shear stress on mTOR expression in vascular endothelial cells. Chen K; Fan W; Wang X; Ke X; Wu G; Hu C Biochem Biophys Res Commun; 2012 Oct; 427(1):138-42. PubMed ID: 22989749 [TBL] [Abstract][Full Text] [Related]
6. MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression. Hu Y; Zhu Q; Tang L PLoS One; 2014; 9(3):e92099. PubMed ID: 24637915 [TBL] [Abstract][Full Text] [Related]
7. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis. Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238 [TBL] [Abstract][Full Text] [Related]
8. MiR-99a Inhibits Cell Proliferation and Tumorigenesis through Targeting mTOR in Human Anaplastic Thyroid Cancer. Huang HG; Luo X; Wu S; Jian B Asian Pac J Cancer Prev; 2015; 16(12):4937-44. PubMed ID: 26163618 [TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure. Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586 [TBL] [Abstract][Full Text] [Related]
10. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer. Zhang J; Kong X; Li J; Luo Q; Li X; Shen L; Chen L; Fang L Oncol Rep; 2014 Mar; 31(3):1357-63. PubMed ID: 24366472 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway. Dai W; Zhao J; Tang N; Zeng X; Wu K; Ye C; Shi J; Lu C; Ning B; Zhang J; Lin Y Liver Int; 2015 Apr; 35(4):1234-43. PubMed ID: 25142507 [TBL] [Abstract][Full Text] [Related]
12. The role of miR-18a in gastric cancer angiogenesis. Zheng Y; Li S; Ding Y; Wang Q; Luo H; Shi Q; Hao Z; Xiao G; Tong S Hepatogastroenterology; 2013 Oct; 60(127):1809-13. PubMed ID: 24624454 [TBL] [Abstract][Full Text] [Related]
13. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer. Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838 [TBL] [Abstract][Full Text] [Related]
14. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer. Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351 [TBL] [Abstract][Full Text] [Related]
15. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer. Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558 [TBL] [Abstract][Full Text] [Related]
17. Loss of SNAIL inhibits cellular growth and metabolism through the miR-128-mediated RPS6KB1/HIF-1α/PKM2 signaling pathway in prostate cancer cells. Tao T; Li G; Dong Q; Liu D; Liu C; Han D; Huang Y; Chen S; Xu B; Chen M Tumour Biol; 2014 Sep; 35(9):8543-50. PubMed ID: 24859886 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells. Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells. Yan B; Fu Q; Lai L; Tao X; Fei Y; Shen J; Chen Z; Wang Q Mol Med Rep; 2012 Sep; 6(3):675-81. PubMed ID: 22751686 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA501-5p induces p53 proteasome degradation through the activation of the mTOR/MDM2 pathway in ADPKD cells. de Stephanis L; Mangolini A; Servello M; Harris PC; Dell'Atti L; Pinton P; Aguiari G J Cell Physiol; 2018 Sep; 233(9):6911-6924. PubMed ID: 29323708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]